Vanta Bioscience Ltd.
BSE: 540729 | Sector: Others |
NSE: N.A. | ISIN Code: INE695X01011 |
BSE 00:00 | 02 Feb | 63.05 |
-3.30 (-4.97%) |
OPEN
63.05 |
HIGH
63.05 |
LOW
63.05 |
NSE 05:30 | 01 Jan | Vanta Bioscience Ltd |
OPEN | 63.05 |
PREVIOUS CLOSE | 66.35 |
VOLUME | 1500 |
52-Week high | 181.00 |
52-Week low | 56.50 |
P/E | 525.42 |
Mkt Cap.(Rs cr) | 40 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Vanta Bioscience Ltd. (VANTABIOSCIENCE) - Announcements
-
Vanta Bioscience Ltd Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
21/01/2023 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
14/01/2023 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (C
11/01/2023 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Shareholder Meeting / Postal Ballot-Scrutinizers Report
02/01/2023 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Shareholder Meeting / Postal Ballot-Outcome of AGM
31/12/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (C
14/12/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd AGM On 31.12.2022
07/12/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (C
27/11/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (C
24/11/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Results-Delay in Financial Results
14/11/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Board Meeting Intimation for Approval Of Unaudited Financials (Standalone & Consolidation) For The H
08/11/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Statement Of Investor Complaints For The Quarter Ended September 2022
20/10/2022 | bse
-
Vanta Bioscience Ltd Closure of Trading Window
30/09/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Appointment of Company Secretary and Compliance Officer
15/09/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Receipt Of Approval From Registrar Of Companies Granting Extension Of Time For Holding The 6Th AGM
07/09/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Application To ROC Hyderabad For Seeking Extension Of Time For Conducting AGM For FY 2021-22
03/09/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
03/09/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (C
17/08/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (C
28/07/2022 | bse |
Downlaod PDF
-
Vanta Bioscience Ltd Statement Of Investor Complaints For The Quarter Ended June 2022
13/07/2022 | bse
Quick Links for Vanta Bioscience:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices